These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 27770537)

  • 1. IMMUNOGENETIC FACTORS INFLUENCING CLINICAL COURSE OF HCV INFECTION (REVIEW).
    Kamkamidze G; Butsashvili M; Gendzekhadze K
    Georgian Med News; 2016 Sep; (258):84-89. PubMed ID: 27770537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.
    de Arias AE; Haworth SE; Belli LS; Burra P; Pinzello G; Vangeli M; Minola E; Guido M; Boccagni P; De Feo TM; Torelli R; Cardillo M; Scalamogna M; Poli F
    Liver Transpl; 2009 Apr; 15(4):390-9. PubMed ID: 19326408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of activating killer immunoglobulin-like receptor genes combined with hepatitis C viral genotype is predictive of hepatocellular carcinoma.
    Littera R; Zamboni F; Tondolo V; Fantola G; Chessa L; Orrù N; Sanna M; Valentini D; Cappai L; Mulargia M; Caocci G; Arras M; Floris A; Orrù S; La Nasa G; Carcassi C
    Hum Immunol; 2013 Oct; 74(10):1288-94. PubMed ID: 23756163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The interaction of genetic determinants in the outcome of HCV infection: evidence for discrete immunological pathways.
    Hydes TJ; Moesker B; Traherne JA; Ashraf S; Alexander GJ; Dimitrov BD; Woelk CH; Trowsdale J; Khakoo SI
    Tissue Antigens; 2015 Oct; 86(4):267-75. PubMed ID: 26381047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chimpanzee susceptibility to hepatitis C virus infection correlates with presence of Pt-KIR3DS2 and Pt-KIR2DL9: paired activating and inhibitory natural killer cell receptors.
    Abi-Rached L; Guethlein LA; Norman PJ; Parham P
    Immunogenetics; 2015 Oct; 67(10):625-8. PubMed ID: 26260270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of genes for killer cell immunoglobulin-like receptors (KIR) to the susceptibility to chronic hepatitis C virus infection and to viremia.
    Kuśnierczyk P; Mozer-Lisewska I; Zwolińska K; Kowala-Piaskowska AE; Bura M; Bereszyńska I; Pauli A; Żeromski J
    Hum Immunol; 2015 Mar; 76(2-3):102-8. PubMed ID: 25636579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural history of hepatitis C virus infection: from chronic hepatitis to cirrhosis, to hepatocellular carcinoma.
    Leone N; Rizzetto M
    Minerva Gastroenterol Dietol; 2005 Mar; 51(1):31-46. PubMed ID: 15756144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural history of hepatitis C.
    Westbrook RH; Dusheiko G
    J Hepatol; 2014 Nov; 61(1 Suppl):S58-68. PubMed ID: 25443346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Host genetic variants influencing the clinical course of hepatitis C virus infection.
    Matsuura K; Tanaka Y
    J Med Virol; 2016 Feb; 88(2):185-95. PubMed ID: 26211651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural history of hepatitis C virus infection.
    Mondelli MU
    J Biol Regul Homeost Agents; 2003; 17(2):128-32. PubMed ID: 14518710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Role of the Regulatory T lymphocytes in hepatitis C fibrosis progression].
    Delhem N; Cottrez F; Carpentier A; Miroux C; Moralès O; François V; Groux H; Auriault C; Pancré V
    Bull Cancer; 2008 Nov; 95(11):1029-38. PubMed ID: 19036674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effect of the HLA-Bw4I80 epitope and the killer cell immunoglobulin-like receptor 3DS1 gene against the development of hepatocellular carcinoma in patients with hepatitis C virus infection.
    López-Vázquez A; Rodrigo L; Martínez-Borra J; Pérez R; Rodríguez M; Fdez-Morera JL; Fuentes D; Rodríguez-Rodero S; Gonzáez S; López-Larrea C
    J Infect Dis; 2005 Jul; 192(1):162-5. PubMed ID: 15942906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Innate immunity against hepatitis C virus.
    Xu Y; Zhong J
    Curr Opin Immunol; 2016 Oct; 42():98-104. PubMed ID: 27366996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disease progression from chronic hepatitis C to cirrhosis and hepatocellular carcinoma is associated with repression of interferon regulatory factor-1.
    Zekri AR; Moharram RA; Mohamed WS; Bahnassy AA; Alam El-Din HM; Abo-Shadi MM; Zayed NA; El-Magzangy H; Abdel-Aziz AO; Esmat G
    Eur J Gastroenterol Hepatol; 2010 Apr; 22(4):450-6. PubMed ID: 19858727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NIH Consensus Statement on Management of Hepatitis C: 2002.
    NIH Consens State Sci Statements; 2002 Jun 10-12; 19(3):1-46. PubMed ID: 14768714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The risk of end stage liver disease and hepatocellular carcinoma among persons infected with hepatitis C virus: publication bias?
    Goodgame B; Shaheen NJ; Galanko J; El-Serag HB
    Am J Gastroenterol; 2003 Nov; 98(11):2535-42. PubMed ID: 14638360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural killer cells in hepatitis C: Current progress.
    Yoon JC; Yang CM; Song Y; Lee JM
    World J Gastroenterol; 2016 Jan; 22(4):1449-60. PubMed ID: 26819513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hepatitis C: epidemiology natural course and diagnosis].
    Moradpour D; Müllhaupt B
    Rev Med Suisse; 2015 Apr; 11(471):896-901. PubMed ID: 26072594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic inflammation associated with hepatitis C virus infection perturbs hepatic transforming growth factor beta signaling, promoting cirrhosis and hepatocellular carcinoma.
    Matsuzaki K; Murata M; Yoshida K; Sekimoto G; Uemura Y; Sakaida N; Kaibori M; Kamiyama Y; Nishizawa M; Fujisawa J; Okazaki K; Seki T
    Hepatology; 2007 Jul; 46(1):48-57. PubMed ID: 17596875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KIR genes and their human leukocyte antigen ligands in the progression to cirrhosis in patients with chronic hepatitis C.
    Marangon AV; Silva GF; de Moraes CF; Grotto RM; Pardini MI; de Pauli DS; Sell AM; Visentainer JE; Moliterno RA
    Hum Immunol; 2011 Nov; 72(11):1074-8. PubMed ID: 21920398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.